verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: baxter healthcare corporation
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler baxter healthcare corporation
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
Baxter Healthcare Corporation

Identifiers & Regulatory

Product NDC 43066-035
Product ID 43066-035_65fb1861-d681-4c27-9428-52df91e72e16
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA213232
Listing Expiration 2026-12-31
Marketing Start 2020-03-25

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 43066035
Hyphenated Format 43066-035

Supplemental Identifiers

RxCUI
1665057 1665061
UPC
0343066035013 0343066031015
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA213232 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 5 VIAL, SINGLE-DOSE in 1 CARTON (43066-035-05) / 4 mL in 1 VIAL, SINGLE-DOSE (43066-035-01)
source: ndc

Packages (1)

43066-035-05 5 VIAL, SINGLE-DOSE in 1 CARTON (43066-035-05) / 4 mL in 1 VIAL, SINGLE-DOSE (43066-035-01)

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "65fb1861-d681-4c27-9428-52df91e72e16", "openfda": {"upc": ["0343066035013", "0343066031015"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["03c5daf8-5399-4d89-a747-9a9d7667b6e4"], "manufacturer_name": ["Baxter Healthcare Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL, SINGLE-DOSE in 1 CARTON (43066-035-05)  / 4 mL in 1 VIAL, SINGLE-DOSE (43066-035-01)", "package_ndc": "43066-035-05", "marketing_start_date": "20200325"}], "brand_name": "Verapamil Hydrochloride", "product_id": "43066-035_65fb1861-d681-4c27-9428-52df91e72e16", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "43066-035", "generic_name": "verapamil Hydrochloride", "labeler_name": "Baxter Healthcare Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA213232", "marketing_category": "ANDA", "marketing_start_date": "20200325", "listing_expiration_date": "20261231"}